Archive: 2016
“Painful Memories” – How Memory Biases Affect Patient-reported Outcome Measures
People are surprisingly bad at remembering past events, both the factual details and how they were feeling at the time. Read More
Taking ePRO to New Places – Replacing Paper
Traditional ePRO solutions can actually demonstrate a positive return on investment (ROI) versus paper for trials with large volumes of assessments. Read More
The Future of Clinical Trial Design Is Here in the Lung-MAP Clinical Trials
We recently caught up with James Moon, a biostatistician at the Fred Hutchinson Cancer Research Center. Read More
How Do iComply? A Look at Regulatory Topics Surrounding the Use of mHealth Technology in Clinical Trials
The mHealth landscape is expanding with over 97,000 apps (mobile applications) as of 2013. Read More
Professional Patients and Deception in Clinical Research Trials
If your trials rely on research participants with a track record of taking part in a number of clinical trials, it might be worth taking a second look and examining them a bit closer. Read More
Eisai Chief Medical Officer Stewart Geary On Clinical Trial Complexity
Clinical trial costs are increasing, and there’s no clear sign that these increased costs are improving the clinical trials process. Read More
Tech’s Role in Moving Towards Home-based Healthcare
Will technology and data overhaul the healthcare system through increases in home-based patient monitoring? Read More
Are Wearables the Next Beepers?
If you think wearable devices are just another tech fad that will go the way of AskJeeves and 3D televisions, think again. Read More
Big Pharma, Meet mHealth; mHealth, Meet Big Pharma
Does Moore's Law translate to older, regulated industries such as pharma? Read More
A Leukemia Drug Takes On Head and Neck Cancers
It’s always interesting to check out what our customers are up to with our platform, and right now Cancer Research UK has a great exploratory trial under way with the experimental drug AMG 319. Read More
